Inhaled corticosteroids and long term outcome in adults with asthma [1]

Thorax

Volumn 61, Issue 11, 2006, Pages 1011-

  Merkus, P J F M ^a   De Jongste, J C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ASTHMA; BRONCHODILATATION; DRUG RESEARCH; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG FUNCTION; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 33751257173     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.062810     Document Type: Letter

References (6)

1. Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006;61:100-4.
2. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006;61:105-10.
3. Ernst P. Inhaled corticosteroids moderate lung function decline in adults with asthma. Thorax 2006;61:93-4.
4. Childhood Asthma Management Program (CAMP) Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.
5. Sont JK, Willems LNA, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;159:1043-51.
6. Merkus PJ, van Pelt W, van Houwelingen JC, et al. Inhaled corticosteroids and growth of airway function in asthmatic children. Eur Respir J 2004;23:861-8.